Bing Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bing Xu has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Qi Han
Shanghai Jiao Tong University School of Medicine
1 shared publication Shengjun Wu
Co-Innovation Center of Jiangsu Marine Bio-Industry Technology, Jiangsu Ocean University, Haizhou, China
1 shared publication- Shengjun Wu
Jiangsu Key Laboratory of Marine Bioresources and Environment/Jiangsu Key Laboratory of Marine Biotechnology Jiangsu Ocean University Haizhou China
1 shared publication
Latest Publications
- 2 March 2021
- Published by Springer Nature in 3 Biotech
- Vol. 11 (3) , 1-6
Effect of dietary astaxanthin administration on the growth performance and innate immunity of juvenile crucian carp (Carassius auratus)
The present study aims to explore the effects of oral astaxanthin administration on the growth performance and innate immunity of juvenile crucian carp (Carassius auratus). Juvenile crucian carps with a bodyweight of 40.06 ± 2.17 g were randomly assigned to four groups, i.e., one control group fed with a basic diet and three treatment groups fed with a diet that contains 200, 400 and 800 mg/kg astaxanthin. After 60 days of feeding, the groups fed with astaxanthin-containing diets had improved body weight gain rate; feed conversion ratio; intestinal digestive protease, lipase and amylase levels; serum superoxide dismutase, catalase, acid phosphatase, alkaline phosphatase and lysozyme activities; complement 3 and complement 4 levels; interleukin (IL)-10 and resistance to Aeromonas hydrophilia and reduced serum aspartate aminotransferase and alanine aminotransferase activities and tumour necrosis factor-α, IL-1β and IL-8 levels compared with those of the control group. Based on the efficiency of the oral administration of astaxanthin on the growth performance of juvenile crucian carps, the optimum dose of astaxanthin was 400 mg/kg. Results indicated that astaxanthin may be used as a dietary supplement for the crucian carp.
- 2 March 2021
- Published by Springer Nature in 3 Biotech
- Vol. 11 (3) , 1-6
Effect of dietary astaxanthin administration on the growth performance and innate immunity of juvenile crucian carp (Carassius auratus)
The present study aims to explore the effects of oral astaxanthin administration on the growth performance and innate immunity of juvenile crucian carp (Carassius auratus). Juvenile crucian carps with a bodyweight of 40.06 ± 2.17 g were randomly assigned to four groups, i.e., one control group fed with a basic diet and three treatment groups fed with a diet that contains 200, 400 and 800 mg/kg astaxanthin. After 60 days of feeding, the groups fed with astaxanthin-containing diets had improved body weight gain rate; feed conversion ratio; intestinal digestive protease, lipase and amylase levels; serum superoxide dismutase, catalase, acid phosphatase, alkaline phosphatase and lysozyme activities; complement 3 and complement 4 levels; interleukin (IL)-10 and resistance to Aeromonas hydrophilia and reduced serum aspartate aminotransferase and alanine aminotransferase activities and tumour necrosis factor-α, IL-1β and IL-8 levels compared with those of the control group. Based on the efficiency of the oral administration of astaxanthin on the growth performance of juvenile crucian carps, the optimum dose of astaxanthin was 400 mg/kg. Results indicated that astaxanthin may be used as a dietary supplement for the crucian carp.
- Open Access
- 20 February 2021
- Published by Springer Nature in 3 Biotech
- Vol. 11 (3) , 1-7
Modulation of the growth performance and innate immunity of loaches (Paramisgurnus dabryanus) upon dietary mannan oligosaccharides
Different levels of mannan oligosaccharides (MOs) (100, 300 and 500 mg kg−1) were incorporated into a basal diet to formulate three diets, which were used to test the growth performance and innate immunity of loaches. The basal diet without any MOs served as the control. Loaches fed with MO-containing diets for 70 days showed a higher specific growth rate, condition factor, survival rate, intestine weight index, intestine length index, intestine Lactobacillus population, intestine Bifidobacterium population, phenoloxidase activity, superoxide dismutase activity, glutathione peroxidase activity, acid phosphatase activity, alkaline phosphatase activity, lysozyme level, complement 3 and resistance to Aeromonas hydrophila than the loaches in the control group. The feed conversion ratio, intestine Escherichia coli population, malondialdehyde level, aspartate aminotransferase level and alanine aminotransferase level showed an opposite trend. The optimal dose of dietary MOs required for the maximum growth of loaches was 300 mg kg−1. Results indicated that dietary MOs promoted the growth performance and innate immunity of loaches and could be used as a dietary supplement for loaches.
- 20 February 2021
- Published by Springer Nature in 3 Biotech
- Vol. 11 (3) , 1-7
Open AccessModulation of the growth performance and innate immunity of loaches (Paramisgurnus dabryanus) upon dietary mannan oligosaccharides
Different levels of mannan oligosaccharides (MOs) (100, 300 and 500 mg kg−1) were incorporated into a basal diet to formulate three diets, which were used to test the growth performance and innate immunity of loaches. The basal diet without any MOs served as the control. Loaches fed with MO-containing diets for 70 days showed a higher specific growth rate, condition factor, survival rate, intestine weight index, intestine length index, intestine Lactobacillus population, intestine Bifidobacterium population, phenoloxidase activity, superoxide dismutase activity, glutathione peroxidase activity, acid phosphatase activity, alkaline phosphatase activity, lysozyme level, complement 3 and resistance to Aeromonas hydrophila than the loaches in the control group. The feed conversion ratio, intestine Escherichia coli population, malondialdehyde level, aspartate aminotransferase level and alanine aminotransferase level showed an opposite trend. The optimal dose of dietary MOs required for the maximum growth of loaches was 300 mg kg−1. Results indicated that dietary MOs promoted the growth performance and innate immunity of loaches and could be used as a dietary supplement for loaches.